Empresa Arca Biopharma Inc Nasdaq
Acciones
US00211Y4070
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 01/10/06 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 10/05/21 |
Sharon Perry
LAW | General Counsel | - | 01/01/08 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 16/02/17 |
Robert Conway
CHM | Chairman | 70 | 03/09/13 |
Linda Grais
BRD | Director/Board Member | 68 | 01/05/07 |
Jacob Ma-Weaver
BRD | Director/Board Member | 37 | 15/06/22 |
James Flynn
BRD | Director/Board Member | 43 | 15/12/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 14 507 143 | 14 320 024 ( 98,71 %) | 0 | 98,71 % |
Información de la empresa
ARCA biopharma, Inc.
10170 Church Ranch Way Suite 100
80021, Westminster
+720 940 2200
http://www.arcabio.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,42 % | 115 mil M | |
+11,84 % | 106 mil M | |
-2,68 % | 21,96 mil M | |
-14,15 % | 21,87 mil M | |
-5,29 % | 19,21 mil M | |
-4,16 % | 18,08 mil M | |
-38,29 % | 17,71 mil M | |
+7,99 % | 14,32 mil M | |
+36,24 % | 12,42 mil M |